Shelton Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-794
| Closed | -$217K | – | 760 |
|
|
2025
Q3 | $217K | Sell |
794
-35
| -4% | -$9.56K | ﹤0.01% | 655 |
|
|
2025
Q2 | $214K | Buy |
+829
| New | +$198K | ﹤0.01% | 642 |
|
|
2024
Q4 | – | Sell |
-870
| Closed | -$212K | – | 775 |
|
|
2024
Q3 | $212K | Buy |
+870
| New | +$194K | 0.01% | 688 |
|
|
2023
Q3 | – | Sell |
-946
| Closed | -$207K | – | 735 |
|
|
2023
Q2 | $207K | Hold |
946
| – | – | 0.01% | 684 |
|
|
2023
Q1 | $207K | Buy |
+946
| New | +$205K | 0.01% | 680 |
|
|
2022
Q4 | – | Sell |
-946
| Closed | -$207K | – | 726 |
|
|
2022
Q3 | $207K | Buy |
+946
| New | +$215K | 0.01% | 627 |
|
|
2022
Q2 | – | Sell |
-946
| Closed | -$229K | – | 791 |
|
|
2022
Q1 | $229K | Hold |
946
| – | – | 0.01% | 709 |
|
|
2021
Q4 | $246K | Hold |
946
| – | – | 0.01% | 677 |
|
|
2021
Q3 | $249K | Hold |
946
| – | – | 0.01% | 651 |
|
|
2021
Q2 | $233K | Buy |
+946
| New | +$199K | 0.01% | 703 |
|
|
2021
Q1 | – | Sell |
-989
| Closed | -$210K | – | 822 |
|
|
2020
Q4 | $210K | Buy |
+989
| New | +$197K | 0.01% | 667 |
|
|
2017
Q3 | – | Sell |
-10,491
| Closed | -$817K | – | 870 |
|
|
2017
Q2 | $817K | Hold |
10,491
| – | – | 0.06% | 259 |
|
|
2017
Q1 | $755K | Buy |
10,491
+2,311
| +28% | +$160K | 0.05% | 268 |
|
|
2016
Q4 | $508K | Buy |
+8,180
| New | +$501K | 0.04% | 355 |
|
|
2016
Q3 | – | Sell |
-13,359
| Closed | -$845K | – | 829 |
|
|
2016
Q2 | $845K | Hold |
13,359
| – | – | 0.07% | 227 |
|
|
2016
Q1 | $772K | Hold |
13,359
| – | – | 0.07% | 247 |
|
|
2015
Q4 | $717K | Hold |
13,359
| – | – | 0.07% | 246 |
|
|
2015
Q3 | $681K | Hold |
13,359
| – | – | 0.08% | 250 |
|
|
2015
Q2 | $753K | Hold |
13,359
| – | – | 0.08% | 238 |
|
|
2015
Q1 | $959K | Sell |
13,359
-1,091
| -8% | -$70.9K | 0.1% | 198 |
|
|
2014
Q4 | $810K | Sell |
14,450
-1,099
| -7% | -$57.4K | 0.09% | 208 |
|
|
2014
Q3 | $766K | Hold |
15,549
| – | – | 0.1% | 203 |
|
|
2014
Q2 | $787K | Hold |
15,549
| – | – | 0.11% | 194 |
|
|
2014
Q1 | $695K | Hold |
15,549
| – | – | 0.1% | 210 |
|
|
2013
Q4 | $732K | Sell |
15,549
-386
| -2% | -$19.5K | 0.11% | 192 |
|
|
2013
Q3 | $842K | Sell |
15,935
-310
| -2% | -$15K | 0.14% | 152 |
|
|
2013
Q2 | $733K | Buy |
+16,245
| New | +$771K | 0.13% | 158 |
|
Other funds holding RMD
Shelton Capital Management's RMD Position: Q4 2025 in Review
Shelton Capital Management sold out of ResMed (RMD) in Q4 2025, closing a stake of 794 shares — an estimated $217K sold.
Shelton Capital Management first reported a position in RMD in Q2 2013 and held it in 27 quarters. The position peaked at $959K in Q1 2015. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.
- Shelton Capital Management reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
- Shelton Capital Management sold 794 ResMed shares in Q4 2025, an estimated $217K.
- Shelton Capital Management first reported a position in ResMed in Q2 2013 and held it in 27 quarters.
- Shelton Capital Management's ResMed position peaked at $959K in Q1 2015.
- 948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.
Based on Shelton Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.